Literature DB >> 3495361

Immunological aspects of the prevention of viral diseases. WHO Workshop.

.   

Abstract

This article summarizes the conclusions of a WHO Workshop which reviewed the role of immunological mechanisms in protection against and recovery from virus diseases. Antibodies are important for preventing infection from some viruses, e.g., influenza virus. In contrast, cell-mediated immunity is more important in the process of recovery from an already established infection. Furthermore, while antibodies are extremely specific in their action, cell-mediated immunity exhibits a greater degree of cross-reactivity. This finding could be useful in designing potential vaccines, particularly attenuated virus vaccines using molecular biological methods. Such an approach could be valuable for poliomyelitis vaccine, whose RNA sequence has now been determined. The possibility of using recombinant vaccinia viruses as a potential vector for other virus antigens is also discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3495361      PMCID: PMC2490846     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  27 in total

1.  Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants.

Authors:  S A Plotkin; M L Smiley; H M Friedman; S E Starr; G R Fleisher; C Wlodaver; D C Dafoe; A D Friedman; R A Grossman; C F Barker
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321

2.  Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell.

Authors:  A J McMichael; B A Askonas
Journal:  Eur J Immunol       Date:  1978-10       Impact factor: 5.532

3.  Location and primary structure of a major antigenic site for poliovirus neutralization.

Authors:  P D Minor; G C Schild; J Bootman; D M Evans; M Ferguson; P Reeve; M Spitz; G Stanway; A J Cann; R Hauptmann; L D Clarke; R C Mountford; J W Almond
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

4.  Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell.

Authors:  A G Morris; Y L Lin; B A Askonas
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

5.  Interferon induction and increased natural killer-cell activity in influenza infections in man.

Authors:  F A Ennis; A Meager; A S Beare; Y H Qi; D Riley; G Schwarz; G C Schild; A H Rook
Journal:  Lancet       Date:  1981-10-24       Impact factor: 79.321

6.  Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons.

Authors:  C W Czarniecki; C W Fennie; D B Powers; D A Estell
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

7.  Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies.

Authors:  A M Arbeter; S E Starr; S R Preblud; T Ihara; P M Paciorek; D S Miller; C M Zelson; E A Proctor; S A Plotkin
Journal:  Am J Dis Child       Date:  1984-05

8.  Cytotoxic T-memory cells in virus infection and the specificity of helper T cells.

Authors:  B A Askonas; A Mullbacher; R B Ashman
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

9.  Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.

Authors:  D M Evans; P D Minor; G S Schild; J W Almond
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

10.  Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus.

Authors:  F A Ennis; A Meager
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.